Valsartan
Valsartan is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Valsartan; Generic name: VALSARTAN; Drug class: Angiotensin 2 Receptor Blocker [EPC].
| Brand name | Valsartan |
|---|---|
| Generic name | VALSARTAN |
| Drug class | Angiotensin 2 Receptor Blocker [EPC] |
| Manufacturer | Direct_Rx |
| Used for | 1.1 Hypertension Valsartan tablets are indicated for the treatment of hypertension, to lower blood pressure in adults and pediatric patients one year of age and older. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which valsartan principally belongs. There are no controlled trials in hypertensive patients demonstrating risk reduction with valsartan tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as |
| Dosage | 2.1 Important Dosage and Preparation Information Valsartan tablets and oral suspension are not substitutable on a milligram-per-milligram basis. Do not combine two dosage forms to achieve the total dose. The systemic exposure to valsartan (AUC) is 60% higher with the suspension compared to tablets [see Clinical Pharmacology (12.3)]. Use of the oral suspension is recommended: in pediatric patients aged 1 to 5 years in patients >5 years of age who cannot swallow tablets and in pediatric patients f |
| Active ingredient(s) | VALSARTAN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=170427e5-c74c-c7fc-e063-6294a90a6860 |